WallStSmart

Stepan Company (SCL)vsSherwin-Williams Co (SHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 903% more annual revenue ($24.41B vs $2.43B). SHW leads profitability with a 11.0% profit margin vs -0.1%. SCL appears more attractively valued with a PEG of 1.75. SHW earns a higher WallStSmart Score of 60/100 (C+).

SCL

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 3.5Value: 4.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.64

SHW

Buy

60

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for SCL.

SHWUndervalued (+2.3%)

Margin of Safety

+2.3%

Fair Value

$330.90

Current Price

$323.31

$7.59 discount

UndervaluedFair: $330.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SCL3 strengths · Avg: 9.3/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
101.6%10/10

Earnings expanding 101.6% YoY

Revenue GrowthGrowth
15.0%8/10

15.0% revenue growth

SHW3 strengths · Avg: 9.0/10
Return on EquityProfitability
69.7%10/10

Every $100 of equity generates 70 in profit

Market CapQuality
$78.49B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

Areas to Watch

SCL4 concerns · Avg: 2.8/10
PEG RatioValuation
1.754/10

Expensive relative to growth rate

Market CapQuality
$1.40B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-1.2%2/10

ROE of -1.2% — below average capital efficiency

Free Cash FlowQuality
$-29.00M2/10

Negative free cash flow — burning cash

SHW4 concerns · Avg: 3.5/10
PEG RatioValuation
2.054/10

Expensive relative to growth rate

P/E RatioValuation
29.3x4/10

Moderate valuation

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Price/BookValuation
20.2x2/10

Trading at 20.2x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : SCL

The strongest argument for SCL centers on Price/Book, EPS Growth, Revenue Growth. Revenue growth of 15.0% demonstrates continued momentum.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap, Free Cash Flow.

Bear Case : SCL

The primary concerns for SCL are PEG Ratio, Market Cap, Return on Equity.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, Altman Z-Score. Debt-to-equity of 3.69 is elevated, increasing financial risk.

Key Dynamics to Monitor

SCL profiles as a turnaround stock while SHW is a value play — different risk/reward profiles.

SHW carries more volatility with a beta of 1.09 — expect wider price swings.

SCL is growing revenue faster at 15.0% — sustainability is the question.

SHW generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

SHW scores higher overall (60/100 vs 58/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Stepan Company

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Stepan Company produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company is headquartered in Northfield, Illinois.

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?